Gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) develops in the context of chronic inflammation caused by Helicobacter pylori infection. Most pathophysiological features of the early stages of MALT lymphomagenesis can be reproduced by experimental infection of BALB/c mice with Helicobacter species. We have previously shown that MALT lymphomas are infiltrated by T-helper cell type 2-polarized T cells and that human and murine tumor B cells carry polyreactive surface immunoglobulins. Using the murine model of the disease, in this study we show that explanted tumor B cells proliferate upon stimulation with the same panel of self and foreign antigens that are recognized by their surface antibodies. Tumor cell proliferation is strongly enhanced by the presence of intratumoral CD4 þ T cells in a CD40/CD40L-independent manner. A large proportion of tumor-infiltrating CD4 þ T cells are CD25 þ FoxP3 þ regulatory T cells (Tregs) with highly suppressive activity, which are recruited by the tumor cells through secretion of the Treg-attracting chemokines CCL17 and CCL22. The depletion of CD25 þ cells was as efficient as CD4 þ T cell depletion in blocking tumor growth in vitro and in vivo. In conclusion, our data suggest that B-cell receptor-derived signals cooperate with T-helper cell signals in driving the progression of MALT lymphoma, providing an explanation for the unique antigen dependence of this B-cell malignancy.
Introduction
Extranodal marginal-zone B-cell lymphomas of mucosa-associated lymphoid tissue (MALT) comprise a group of low-grade non-Hodgkin's lymphomas that arise in the context of chronic lymphoid proliferation in a variety of mucosal sites. A majority of cases are found in the stomach, in which they develop against a background of chronic active gastritis caused by the Gramnegative bacterium Helicobacter pylori.
1,2 In a subset of infected individuals, H. pylori-induced chronic inflammation can give rise to organized lymphoid tissue, from which individual malignant clones grow out and form the lymphoepithelial lesions typical of gastric MALT lymphoma. 2 Low-grade MALT lymphomas are characterized by an indolent clinical course; they grow slowly, rarely undergo high-grade transformation and typically remain localized to their primary site.
In its early stages, MALT lymphoma is believed to be an antigen-dependent disease, relying on antigenic and/or helper T cell-derived growth signals and being incapable of autonomous growth. 1, 3, 4 Several lines of evidence argue that, in the case of gastric MALT lymphomas, the antigenic signals are provided by infection with H. pylori. Ongoing or past infection with the bacterium is detectable in a large majority of cases, 1, 2, 5 and eradication of the bacterium leads to regression of early-stage tumors. 3, 4 In certain mouse strains, long-term experimental infection with H. pylori or its close relatives H. felis or H. heilmannii is sufficient to induce gastric B-cell lymphomas that histologically and biologically resemble the human disease counterpart. [6] [7] [8] The murine tumors are slow growing, regress upon eradication of the infection and recur rapidly upon re-introduction of the bacterium. 6, 7 Despite its generally benign nature, a small fraction of gastric MALT lymphomas ultimately undergo high-grade transformation or acquire one of several known characteristic chromosomal translocations, 9 thereby rendering the lymphoma antigen independent and refractory to H. pylori eradication therapy. The shared outcome of all chromosomal translocations identified to date is the constitutive activation of the nuclear factor-kB signaling pathway, leading to B-cell receptor (BCR)-independent proliferation of the tumor B cells. 9 We and others have reported previously that gastric MALT lymphomas are infiltrated by large numbers of T-helper cells expressing interleukin-4 and other T-helper cell type 2 cytokines. 7, 10 The tumor B cells carry rearranged somatically mutated immunoglobulins on their surface, [11] [12] [13] [14] which have undergone positive selection. 13, 15 We have recently shown that recombinant tumor immunoglobulins derived from both human and murine MALT lymphomas are polyreactive; that is, they bind to a panel of foreign and autoantigens with similar affinity. 14 Moreover, the tumor cells preferentially use the Ig heavy chain V H gene segment 1-69 that has previously been linked to polyreactive and autoantibodies in other B-cell malignancies or autoimmune pathologies. 14 Using the BALB/c mouse model of Helicobacter-induced gastric MALT lymphoma, in this study we elucidate the relative contribution of BCR-derived and T-helper cell-derived signals in MALT lymphoma growth in vitro and in vivo. We observe that purified tumor B cells proliferate in response to the same range of antigens that are recognized by recombinant tumor Ig. Tumor-infiltrating T cells contribute to maximal tumor cell proliferation. A significant fraction of tumor-infiltrating T cells are CD25 þ regulatory T cells (Tregs) with strong suppressive activity, which are recruited by the tumor B cells in a CCL17/ CCL22-dependent manner. The depletion of either Tregs or all CD4 þ T cells in vivo efficiently induces tumor regression, implying that T cell-derived signals are required for MALT lymphomagenesis.
Materials and methods

Animal experimentation, tumor cell cultures and proliferation assays
Specific pathogen-free female BALB/c mice were infected orally at 6 weeks of age with three consecutive doses of B5 Â 10 7 H. felis (CS1, American Type Culture Collection 49179) and maintained for 18 months in individually ventilated cages. For in vivo depletion of T cells, mice received biweekly intraperitoneal injections of 300 mg anti-CD4 monoclonal antibody (YTS 191; Bio X Cell, West Lebanon, NH, USA) or anti-CD25 monoclonal antibody (PC-61.5.3; Bio X Cell). All animal experiments were performed in accordance with the institutional policies and were approved by the cantonal veterinary office. Upon killing by CO 2 inhalation, the stomachs were removed and dissected along the lesser curvature; longitudinal sections of each stomach were fixed in 10% neutral-buffered formalin before paraffin embedding, sectioning and hematoxylin and eosin staining. Another section was subjected to isolation of genomic DNA followed by quantitative analysis of Helicobacter colonization using real-time PCR as described. 16 From the remaining stomach tissue, tumors of 41 mm diameter were excised, and single-cell suspensions were generated and cultured in RPMI supplemented with 10% fetal calf serum and penicillin/ streptomycin. Helicobacter lysate, lipopolysaccharide, singlestranded DNA, immunoglobulin G (IgG), gastric mucosal protein extract and bovine serum albumin were added at 10 mg/ml. Helicobacter lysate and gastric mucosal extract were prepared as described previously.
14 Supernatants of tumor cell suspensions were harvested for Treg conversion assays as described in the Supplementary Methods. CD4
þ , CD25 þ and CD154 þ T cells were depleted from the tumor cell suspensions by immunomagnetic depletion using biotinylated monoclonal antibodies (anti-CD4 clone RM4-5, anti-CD154 clone MR1, both from BD Biosciences, CA, USA; anti-CD25 clone PC61.5, R&D Systems, Minneapolis, MN, USA) followed by streptavidincoated magnetic beads. Blocking of the CD40/CD40L interaction was achieved with 10 mg/ml of anti-CD40L antibody (clone MR1, low endotoxin, azide free; BD Biosciences). Tumor cell proliferation was quantified by [ 3 H]-thymidine incorporation assay, or by 5-bromodeoxyuridine (BrdU) incorporation, followed by fluorescence-activated cell sorting analysis using a fluorescent in situ cell proliferation kit (Roche Diagnostics, Mannheim, Germany) in combination with a fluorescently labeled anti-CD19 antibody (clone 6D5; Abcam, Cambridge, UK). Tumor cell suspensions were phenotyped by fluorescenceactivated cell sorting and subjected to immunomagnetic isolation of Tregs as described in the Supplementary Methods. Tumor-derived Tregs were assessed for their ability to migrate and to suppress effector T-cell proliferation, as described in detail in the Supplementary Methods.
Patient material
Human patient material was obtained from seven patients with gastric low-grade MALT lymphoma who were part of a previously published study conducted at Philipps University Hospital (Marburg, Germany). 17 . All tumors were diagnosed as H. pylori-positive low-grade gastric MALT lymphomas and all were negative for the translocation t(11;18)(q21;q21). A tumor biopsy as well as biopsy material from adjacent unaffected tissue (with histological evidence of chronic gastritis) was secured from all seven patients. For the histopathological analysis of archived patient material, consecutive cases of H. pyloripositive gastritis, of H. pylori-positive gastric low-grade MALT lymphoma and of gastric high-grade MALT lymphoma were drawn from the surgical pathology files of the Institute of Pathology at the Cantonal Hospital (St Gallen, Switzerland) and the Institute of Pathology, Klinikum Bayreuth, (Bayreuth, Germany). All data were blinded to guarantee patients' protection. This procedure is in agreement with the guidelines for use of human material in research issued by the ethics committees of both institutions. The patient material was used for the quantitative analysis of FoxP3 and CD4 expression by immunohistochemistry and real-time reverse transcriptase-PCR, as described in detail in the Supplementary Methods.
Results
Murine MALT lymphoma B cells proliferate ex vivo in response to antigens recognized by their BCR
We have reported recently that recombinantly expressed antibodies consisting of matching heavy and light chain sequences derived from murine and human MALT lymphomas bind to a variety of target antigens, including autoantigens such as IgG and single-stranded DNA, as well as foreign antigens such as Helicobacter and Escherichia coli extract or lipopolysaccharide. 14 To investigate the functional consequences of antigen binding by the tumor cells, which are IgM þ and express functional BCR on their surface, 14 we generated single-cell suspensions from macroscopically discernible tumors that we dissected from the stomachs of H. felis-infected BALB/c mice. The tumor cell suspensions were cultured for 5 days in the presence of Helicobacter extract, lipopolysaccharide, gastric mucosal extract, IgG and single-stranded DNA before quantification of proliferation by [ 3 H]-thymidine incorporation. The whole panel of cognate antigens stimulated tumor cell proliferation compared with untreated controls (Figure 1a) , whereas bovine serum albumin, which is not recognized by recombinant tumor Ig, 14 did not induce proliferation ( Figure 1a ). In parallel to culturing unsorted tumor suspensions, which contained a significant portion of admixed non-B cells (see below), we specifically enriched for the tumor B cells by immunomagnetic depletion of all other cell types. The resulting B-cell populations (which were 495% pure) showed a similar relative reactivity toward the panel of target antigens ( Figure 1b) ; however, their overall proliferative response was reduced by 90% compared with the unsorted cultures. The results confirm that MALT lymphoma B cells carry functional, polyreactive Ig on their surface and may receive proliferative signals through their BCR. However, additional tumor-infiltrating cell types are required for a maximal response to cognate antigen.
Murine MALT lymphomas are infiltrated by activated, immunocompetent CD4 þ T cells
To quantify and phenotype the tumor-infiltrating cell populations, we generated single-cell suspensions from 10 independent tumors and analyzed their expression of T cells, B cells and myeloid markers. As shown in previous studies, a majority of leukocytes in the suspensions were CD19 þ B cells (on average 67%, Figure 2a) ; a small fraction was positive for the myeloid markers CD11b or CD11c (2%, Figure 2a 
Intratumoral Tregs are highly suppressive in vitro
On the basis of the effect that the depletion of intratumoral CD25 þ cells has on tumor cell proliferation, we hypothesized that the tumors should be enriched for Tregs. We confirmed this by quantitative expression analysis of the Treg lineage-defining transcription factor FoxP3 ( Figure 4a ); dissected murine gastric MALT lymphomas expressed significantly higher levels of FoxP3 than directly adjacent tissue with histologically confirmed gastritis and also more than the gastric mucosa of an uninfected age-matched mouse (Figure 4a ). To assess the suppressive activity of intratumoral Tregs in a standardized suppression assay, we immunomagnetically isolated CD4 þ CD25 þ cells from tumor cell suspensions and from the corresponding mesenteric lymph nodes and spleen. Treg yields were between 6 and 8.3% of the total tumor cell population. The CD25
þ Treg populations were mixed with effector T cells in a 1:1 ratio, and the co-cultures were stimulated with anti-CD3/CD28 monoclonal antibody-coated beads (Figure 4b ). The suppressive activity of intratumoral Tregs was significantly higher than that of the splenic and mesenteric lymph node-derived Tregs isolated from the same donor ( Figure 4b ). We conclude from these results that the tumors are infiltrated by Tregs that are highly Tregs are recruited to MALT lymphomas through the activity of tumor B cell-derived chemokines Tregs are actively recruited by a variety of epithelial cancers, and this phenomenon is believed to benefit the tumors by blocking local antitumor immune responses. [18] [19] [20] Treg recruitment into the microenvironment of ovarian and gastric cancer requires the activity of either or both of the two chemokines, CCL17 and CCL22, 18, 21 which bind to a shared receptor on the Treg surface, CCR4. To investigate whether MALT lymphoma B cells might actively recruit Tregs to the tumor mass using the same mechanism, we first investigated CCL17 and CCL22 expression in tumor compared with matched gastritic tissue and uninfected normal gastric mucosa (Figure 5a ). Indeed, transcript levels of both chemokines were significantly higher in the tumors compared with adjacent inflamed tissue or normal mucosa (Figure 5a) .
To measure the chemoattraction of spleen-derived natural (CD4 þ CD25 þ ) Tregs by MALT lymphoma supernatants generated by culturing single-cell suspensions ex vivo as described above (Figures 1 and 3 ), we established a transwell migration assay in which the Tregs were fluorescently labeled and allowed to migrate toward supernatants of tumor cell cultures. The supernatants of cultures that had been induced to proliferate by addition of Helicobacter extract recruited Tregs more efficiently than the supernatants of unstimulated tumor cells (Figure 5b ). The depletion of total CD4 þ , CD40L þ or CD25 þ T cells, which prevented tumor cell proliferation upon stimulation (Figure 3) , also significantly reduced the chemoattraction of Tregs by the corresponding supernatants (Figure 5b ). Purified tumor B cells that had been stimulated with Helicobacter extract also induced less migration than the undepleted culture (Figure 5b ). Interestingly, Treg migration could be partially blocked by neutralization of either CCL17 or CCL22. Neutralization of both chemokines together completely abrogated Treg migration toward the supernatants of all cultures (Figure 5b ). In summary, the results imply that actively growing (but not resting) tumor cells possess the ability to recruit Tregs; this process is mediated by two partially redundant chemokines that bind to the same receptor, CCR4. The observation that Treg chemoattraction is maintained at least partially in pure B-cell cultures and is It is now well established that FoxP3 þ Tregs not only arise in a thymus-dependent process (the 'natural' or nTreg subset), but can also be generated in the periphery through a combination of T-cell receptor-mediated signals and transforming growth factorb (TGF-b) exposure (the so-called 'inducible' Treg). To explore whether Tregs can be converted from conventional T cells directly in the tumor microenvironment in addition to being recruited there, we cultured reporter cells expressing enhanced green fluorescent protein under the FoxP3 promoter in the presence of tumor cell culture supernatant (Figure 6a ). Whereas the supernatants of unstimulated tumor cell cultures had no effect on FoxP3 expression, supernatants of Helicobacter extract-stimulated (that is, proliferating) tumor cells induced the conversion of conventional T cells to FoxP3 þ Tregs almost as efficiently as a positive control consisting of a CD3-crosslinking antibody and recombinant interleukin-2 and TGF-b (Figure 6a ). Supernatants from parallel cultures of the corresponding splenocytes from the same donor did not induce Treg conversion, independent of whether the splenocytes had been stimulated by Helicobacter extract or not. These data were confirmed by quantitative real-time reverse transcriptase-PCR analysis of FoxP3 expression in a parallel experiment (Figure 6b) . Overall, the data suggest that proliferating MALT lymphoma cells produce as-yet-unidentified soluble factors that allow them to convert Tregs from conventional T cells in situ in addition to recruiting them through the activity of Treg chemoattractants.
Depletion of CD4
þ or CD25 þ cells in vivo induces MALT lymphoma regression
To determine whether CD4
þ T cells and their CD25 þ subset would be as essential for tumor cell proliferation in vivo as they are in vitro (Figure 3) , we depleted both subsets with neutralizing antibodies during the last 3 months of an 18-month infection experiment. H. felis infection-induced gastric MALT lymphomas start to appear as macroscopically visible nodules between 15 and 18 months after infection, 6, 8 leaving a therapeutic window of 3 months before the mice become morbid as a result of their lymphoma burden. Upon killing, the stomachs were removed and macroscopically visible tumors were counted (Figure 7a ). The infected mice that had not received T-cell-depleting antibodies had developed anywhere 
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VJ Craig et al from 2 to 15 tumors, predominantly at the forestomach/corpus junction along the greater curvature. One mouse was still tumor free at 18 months (Figure 7a ). In contrast, none of the CD4 þ T-cell-depleted mice had developed lymphoma and only one mouse of the CD25 þ T-cell-depleted group had a single tumor (Figure 7a ). The depletion efficiency with the CD4-depleting antibody at the time of killing was on average 99.6%, as determined flow cytometrically in the spleens of all mice of the group, whereas the depletion of CD25 þ cells was on average 89.3% efficient for the CD4 þ CD25 þ subset of T cells, and reduced the total subpopulation of splenic CD4 þ T cells by 28.3%. Histopathological analysis of the three groups of mice confirmed the macroscopical observations (Figure 7b ). Only mild-to-moderate symptoms of gastritis could be detected in the mice of the depleted groups, whereas the untreated groups harbored multiple histologically evident tumors (Figure 7b) . Helicobacter colonization was reduced in the CD4-depleted group but not the CD25-depleted group (Figure 7c ) compared with the untreated mice, possibly because of the fact that the mucosal lining of the CD4-depleted mice showed histological signs of atrophy (Figure 7b ), a condition that does not support growth of the bacteria. 16 In conclusion, the depletion of CD4 þ and CD25 þ T cells in vivo efficiently blocked lymphomagenesis or led to the regression of pre-existing tumors.
Human low-grade gastric MALT lymphomas are heavily infiltrated by FoxP3
þ Tregs and express the Treg-recruiting chemokines CCL17 and CCL22
To investigate whether human gastric MALT lymphomas are as heavily infiltrated by CD4 þ T cells and Tregs as their murine disease counterparts, we obtained archived material from patients with low-grade (n ¼ 10) or high-grade MALT lymphoma (n ¼ 7; Figures 8a and b) . Several cases with gastritis were assessed for comparison (n ¼ 4). Consecutive paraffin sections were immunohistochemically stained for CD4 and FoxP3; hematoxylin and eosin-stained sections were used to confirm the initial diagnosis (Figure 8a) . We quantified the CD4 þ and FoxP3 þ populations infiltrating the tissues by counting a minimum of 500 cells per specimen (Figure 8b) . Whereas in the low-grade lymphomas an average of 15.6% of cells in the tumors were CD4 þ , this number was lower in the high-grade þ CD25 þ Tregs were isolated from the spleen of an uninfected donor mouse, labeled with the acetomethoxy derivate of calcein (calcein AM) and seeded into the upper chamber of a transwell chemotaxis plate. Supernatants collected from the undepleted tumor cell cultures (stimulated or unstimulated, indicated by À and þ ) as well as from the CD4-, CD40L-and CD25-depleted cultures shown in Figure 3 were placed in the lower chamber. The supernatants collected from purified tumor B cells (Figure 1b) were tested as well. Where indicated, neutralizing antibodies to CCL17 and/ or CCL22 were added to the lower chamber at 2 mg/ml. Treg migration was quantified fluorospectrometrically; the fraction of migrated cells in percentage of input was calculated based on a standard curve of known cell number. Averages and s.d. of duplicate readings are shown. The effect of CCL17 and CCL22 neutralization was confirmed four times on undepleted supernatants and twice on depleted supernatants. cases (4.8%), and higher in the gastritis cases (35%, Figure 8b) . Interestingly, the Treg population was substantial in many of the low-and high-grade lymphomas, making up on average 33% of the whole CD4 þ population in both groups (Figure 8b ). Tregs were less abundant in the gastritis cases (9.2% of CD4 þ ); their proportion as a fraction of all CD4 þ cells was therefore much closer to the 'normal' ratio of 10-15% of CD4 þ cells in the periphery as reported for humans. The accumulation of FoxP3 þ cells was further confirmed by quantitative real-time reverse transcriptase-PCR, which we conducted on matched pairs of low-grade MALT lymphoma and corresponding gastritis tissues from seven patients who had been diagnosed with H. pyloripositive, translocation-negative gastric MALT lymphoma (Figure 8c) . The over-representation of FoxP3 transcript in the tumor biopsy material in comparison to normal inflamed surrounding tissue confirmed the accumulation of Tregs, specifically in the tumors. The RNA isolated from the human lymphoma/gastritis pairs further allowed us to quantify the expression of the Treg-recruiting chemokines CCL17 and CCL22 (Figure 8d ). Interestingly, both were expressed significantly higher in tumor tissue compared with corresponding gastritis (Figure 8d) . No correlation between the two chemokines was observed, suggesting that they are regulated independently of each other. In conclusion, human low-grade MALT lymphomas are infiltrated by large numbers of FoxP3 þ Tregs, which may be recruited to the tumor mass through the same mechanism used by their murine counterparts.
Discussion
We have shown previously that Helicobacter-dependent murine MALT lymphomas are infiltrated by large numbers of CD4 þ T cells, and that the tumor B cells express functional, rearranged, polyreactive immunoglobulins on their surface. 14 In this study we have assessed the relative contribution of proliferative signals originating from the BCR and from tumorinfiltrating T-helper cells to tumor cell growth in vitro and in vivo. Several hypotheses addressing the pathogenesis of MALT lymphoma, which had been raised previously based on histopathological observations and, to some extent, experimental manipulation of human biopsy material, were confirmed and extended by our results, and underscore the unique status that MALT lymphomas have among B-cell malignancies with respect to their dependence on external signals.
The availability of definitive clinical evidence proving that low-grade MALT lymphomas regress upon eradication of the causative 'antigen', H. pylori, 3, 4 led to the postulation of a role for BCR signaling in MALT lymphomagenesis, 11, [22] [23] [24] [25] [26] and sparked a search for potential tumor antibody targets. Most studies have implicated autoantigens, ranging in diversity from (unspecified) antigens expressed on follicular dendritic cells and post-capillary venules 24 to antigens of plasma cells 26 and autoIgG. 11 However, the functional significance of antigen binding has not been shown for these targets because of the difficulties in obtaining sufficient amounts of viable tumor cell material for ex vivo culturing (surgical biopsies have not been available since Helicobacter eradication therapy replaced surgery as the firstline treatment of gastric low-grade MALT lymphoma) and the lack of MALT lymphoma cell lines. We show here that purified tumor B cells isolated from whole tumor cell suspensions proliferate upon exposure to a variety of target antigens, which were shown previously to be recognized by tumor-derived immunoglobulins.
14 Whereas it can be argued that some antibody targets (H. felis sonicate and single-stranded DNA) contain Toll-like receptor ligands and therefore could in principle trigger proliferation of B cells through crosslinking of Toll-like receptors, this is not the case for other targets tested (gastric mucosal extract and IgG). We deduce from this result that tumor B cells can be stimulated through their BCR. This conclusion is further supported by the intriguing finding that MALT lymphoma immunoglobulins are subject to ongoing somatic hypermutation, 11, 13, 15 yet avoid class switch recombination, 27 indicating that surface IgM-positive tumor cells are favored by positive or negative selective forces. At the molecular level, the resistance of MALT lymphoma B cells to isotype switching has been explained by their propensity to undergo aberrant class switch recombination, 27 a process by which the IgH locus recombines in a way so that switch regions are deleted and the IgM þ status is conserved. Although isolated tumor B cells replicate upon addition of their cognate antigen, their proliferation can be enhanced approximately tenfold by the presence of tumor-infiltrating T cells. This result suggests that MALT lymphoma B cells resemble normal B cells with respect to their reliance on T-cell help. Tumor-infiltrating CD4 þ T cells coexpress CD40L and the activation marker CD69 and produce large quantities of T-helper cell type 2 cytokines such as interleukin-4. 7, 28 By depleting CD40L þ cells from the cultures, we found that this population was essential for providing B-cell stimulatory signals. However, blocking the direct interaction between CD40L and its receptor did not abrogate tumor cell proliferation. This suggests that soluble activated T cell-derived signals are more important than a direct interaction between both cell types for inducing tumor B-cell proliferation. Our data confirm previous results by Greiner et al.
22
, who reported CD40L expression on human MALT lymphoma-infiltrating T cells. Greiner et al. 28 were able to culture human explanted MALT lymphoma cells in the 'CD40 system', that is, under constant stimulation with agonistic CD40 antibody in conjunction with T-helper cell type 2 cytokines, which led them to conclude that CD40 signaling was essential for tumor B-cell proliferation. In light of our findings it seems that although the tumor B cells can in principle respond to agonistic CD40 stimulation because of high CD40 expression, 7 the direct interaction between both cell types through CD40/CD40L is not required for tumor cell proliferation, at least in vitro.
Several groups have reported that tumor-infiltrating T cells are specific for H. pylori, 29, 30 and have postulated that T cells rather than tumor B cells constitute the Helicobacter-specific component of the tumor mass. This assumption fits very well with our model; however, we found that purified T cells from other compartments such as the spleen, which should be only modestly enriched for H. pylori reactivity, 16 are also able to significantly enhance tumor cell proliferation.
An unexpected finding of our study was the striking overrepresentation of FoxP3 þ Tregs in the tumor-infiltrating T-cell compartment, both in the murine tumors and in human patient biopsy material that was compared with the respective adjacent gastritic tissue. Much work in recent years has focused on intratumoral Tregs and their putative role in fostering an immune-privileged niche and blocking antitumor immunity. [18] [19] [20] In our model of Helicobacter infection-induced low-grade MALT lymphoma, the depletion of Tregs in the final 3 months of lymphomagenesis reduced the tumor burden as efficiently as the depletion of all CD4 þ T cells, presumably by inducing the regression of pre-existing tumors. This finding was supported by an equally robust effect of Treg depletion on tumor cell proliferation in vitro.
Tregs can be recruited, expanded or converted in the tumor microenvironment. 18, 19 We found evidence for two distinct mechanisms that MALT lymphoma cells use to enhance Treg infiltration. On one hand, supernatants from actively proliferating (but not resting) tumor cells were capable of inducing Tregs de novo from conventional T cells in the absence of a TCR-mediated stimulus. Treg conversion was thus mediated by a soluble factor, but was independent of TGF-b, as addition of a TGF-b-neutralizing antibody did not block conversion (data not shown). On the other hand, tumor cell supernatants efficiently recruited Tregs across transwell filters; again, only the supernatants of proliferating tumor cells had Treg-recruiting activity. Pure populations of malignant tumor B cells, as well as T-cell-depleted tumor cell suspensions, retained much of their ability to recruit Tregs, suggesting that the malignant B cells themselves rather than tumor-infiltrating T cells are the source of Treg chemoattractants in the culture supernatants.
The recruitment of Tregs depended on the two chemokines, CCL17 (also known as thymus and activation-related chemokine, TARC) and CCL22 that, either alone or in combination, had previously been shown to recruit Tregs into epithelial cancers of the stomach 21 and ovaries. 18 Production of these chemokines by malignant B cells has also been shown in follicular lymphoma 31 and in Epstein-Barr virus-associated B-cell lymphoproliferative disorders, 32 although the significance of CCL17 and CCL22 production is less clear in these scenarios. In follicular lymphoma, Treg accumulation in the tumor mass has been attributed mostly to the conversion of Tregs from conventional T cells, which, as in our case, is independent of TCR stimulation and also independent of TGF-b. 31 Interestingly, we found that intratumoral Tregs were highly suppressive against autologous T cells, more so than natural CD25 þ Tregs isolated from the corresponding spleens and mesenteric lymph nodes of the tumor Treg donors. Whether the suppressive activity of intratumoral Tregs is required for their tumor-promoting function cannot be clarified definitively in our experimental setting. However, two observations argue against the notion that low-grade MALT lymphomas benefit from intratumoral Tregs through mechanisms of immune privilege, and instead favor the concept that malignant B cells are directly stimulated by Treg-derived contact-dependent or soluble signals. First, Treg depletion prevents tumor B-cell proliferation in vitro, an effect that can hardly be attributed to enhanced antitumor immune responses. Secondly, high-grade transformed gastric lymphomas harbor less, not more, Tregs and overall CD4 þ T cells compared with their low-grade counterparts. Therefore, Treg numbers are not a suitable prognostic marker for gastric lymphoma, which has a good prognosis at early (low grade) stages and a poor prognosis upon high-grade transformation. Rather, low numbers of Treg and overall infiltrating T cells are in line with the clinical finding that high-grade lymphomas are antigen independent and cannot be treated by Helicobacter eradication therapy because of their acquisition of chromosomal translocations and mutations that affect, among others, the BCL6 gene. 33, 34 Future research will delineate the mechanisms through which Tregs promote tumor B-cell proliferation in the ex vivo culture model introduced here; for example, the neutralization of soluble or contact-dependent Treg-derived signals such as interleukin-10, TGF-b or CTLA-4 should clarify whether these are crucial for promoting tumor cell proliferation ex vivo.
In summary, our results provide evidence that low-grade MALT lymphoma B cells require at least two independent signals for proliferation in vitro and in vivo. One signal is received through surface-exposed tumor immunoglobulin, which is polyreactive and binds multiple unrelated self and foreign antigens with similar affinity. The other signal is provided by tumor-infiltrating T cells, which can enhance B-cell growth through contact-independent mechanisms. The overrepresentation of Tregs compared with conventional CD4 þ T cells in both the human and murine tumor microenvironment and their active recruitment through tumor B cell-derived chemokines argue in favor of a direct role for this population in stimulating tumor growth. Identification of the microenvironmental molecules critical for tumor growth may lead to specific new intervention strategies for the treatment of MALT lymphoma and other antigen-dependent malignancies.
